PR Newswire
NASHVILLE, Tenn., May 3, 2016
NASHVILLE, Tenn., May 3, 2016 /PRNewswire/ -- Cumberland
Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2016 financial results after the
market closes on Tuesday, May 10, 2016. A conference call and live Internet webcast will be
held on Tuesday, May 10, 2016, at 4:30 p.m. Eastern Time to discuss
the results.
To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A
rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers)
or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 87898815. The live webcast and
rebroadcast can be accessed via Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and
commercialization of branded prescription products. The Company's primary target markets include hospital acute care and
gastroenterology. Cumberland's marketed products include Acetadote®
(acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor®
(ibuprofen) Injection, for treatment of pain and fever, Kristalose® (lactulose) for Oral
Solution, a prescription laxative, Vaprisol® (conivaptan) Injection, for the treatment of
hyponatremia and Omeclamox-Pak® for the treatment of H. pylori and duodenal ulcer disease.
Cumberland is also developing Hepatoren® (ifetroban) Injection
for the treatment of Hepatorenal Syndrome and Boxaban® (ifetroban) Oral Capsule for treatment of
aspirin-exacerbated respiratory disease. Cumberland is dedicated to providing innovative
products that improve quality of care for patients. For more information on Cumberland's
approved products, including full prescribing information, please visit the individual product websites, links to which can be
found on the company's website www.cumberlandpharma.com.
Logo - http://photos.prnewswire.com/prnh/20140505/84325
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-to-announce-first-quarter-2016-financial-results-300261437.html
SOURCE Cumberland Pharmaceuticals Inc.